Wu C - Search Results

1

Furin: A Potential Therapeutic Target for COVID-19.

Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, Liu Y, Zhang Q, Zhang P, Wang Y, Wang Q, Xu Y, Zhou Y, Zhang Y, Chen L, Li H. Wu C, et al. iScience. 2020 Oct 23;23(10):101642. doi: 10.1016/j.isci.2020.101642. Epub 2020 Oct 5. iScience. 2020. PMID: 33043282 Free PMC article.

2

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H. Wu C, et al. Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27. Acta Pharm Sin B. 2020. PMID: 32292689 Free PMC article.

3

Structure based discovery of novel hexokinase 2 inhibitors.

Liu Y, Li M, Zhang Y, Wu C, Yang K, Gao S, Zheng M, Li X, Li H, Chen L. Liu Y, et al. Among authors: wu c. Bioorg Chem. 2020 Mar;96:103609. doi: 10.1016/j.bioorg.2020.103609. Epub 2020 Jan 21. Bioorg Chem. 2020. PMID: 32007722

4

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Li M, Wu C, Yang Y, Zheng M, Yu S, Wang J, Chen L, Li H. Li M, et al. Among authors: wu c. Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18. Cell Oncol (Dordr). 2021. PMID: 33735398 Review.

5

A natural DYRK1A inhibitor as a potential stimulator for β-cell proliferation in diabetes.

Zheng M, Zhang Q, Zhang C, Wu C, Yang K, Song Z, Wang Q, Li C, Zhou Y, Chen J, Li H, Chen L. Zheng M, et al. Among authors: wu c. Clin Transl Med. 2021 Jul;11(7):e494. doi: 10.1002/ctm2.494. Clin Transl Med. 2021. PMID: 34323401 Free PMC article. No abstract available.

6

Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor.

Sun W, Wu Y, Zheng M, Yang Y, Liu Y, Wu C, Zhou Y, Zhang Y, Chen L, Li H. Sun W, et al. Among authors: wu y, wu c. J Med Chem. 2020 Aug 13;63(15):8146-8156. doi: 10.1021/acs.jmedchem.0c00377. Epub 2020 Jul 30. J Med Chem. 2020. PMID: 32667202

7

New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense.

Bao F, Yang K, Wu C, Gao S, Wang P, Chen L, Li H. Bao F, et al. Among authors: wu c. Fitoterapia. 2018 Mar;125:123-129. doi: 10.1016/j.fitote.2018.01.001. Epub 2018 Jan 4. Fitoterapia. 2018. PMID: 29305912

8

A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity.

Wu C, Zheng M, Gao S, Luan S, Cheng L, Wang L, Li J, Chen L, Li H. Wu C, et al. Oncotarget. 2017 Dec 8;8(69):113516-113530. doi: 10.18632/oncotarget.23058. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371926 Free PMC article.

9

Glutaminase inhibitors: a patent review.

Wu C, Chen L, Jin S, Li H. Wu C, et al. Expert Opin Ther Pat. 2018 Nov;28(11):823-835. doi: 10.1080/13543776.2018.1530759. Epub 2018 Oct 11. Expert Opin Ther Pat. 2018. PMID: 30273516 Review.

10

Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.

Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L. Wang W, et al. Among authors: wu y, wu c. Eur J Med Chem. 2019 Jul 1;173:282-293. doi: 10.1016/j.ejmech.2019.04.022. Epub 2019 Apr 16. Eur J Med Chem. 2019. PMID: 31009914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,719 results

Search Page